Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

Jeffrey M. Venstrom, Ted A. Gooley, Stephen Spellman, James Pring, Mari Malkki, Bo Dupont, Effie Petersdorf, Katharine C. Hsu

Blood (2010) 115 (15): 3162–3165.

https://doi.org/10.1182/blood-2009-08-236943

Published: 2010

Includes: Supplemental data

Journal Articles

Genetic Allelic Variation in the p53 DNA Repair Pathway Constitute a Risk Factor for Long-Term Survival in Hematopoietic Stem Cell Transplantation

Stige. Bojesen, Mari Malkki, Ted Gooley, Lue Ping Zhao, Annamalai Selvakumar, Stephen R Spellman, MS, Effie W Petersdorf, MD, John A. Hansen, MD, Bo Dupont

Blood (2008) 112 (11): 337.

https://doi.org/10.1182/blood.V112.11.337.337

Published: 2008

Journal Articles

Lack of HLA Class I Ligands for Autologous Inhibitory KIR Is Associated with Improved Survival Following Autologous Stem Cell Transplant for Children with Neuroblastoma.

Jeffrey M Venstrom, MD, Junting Zheng, MA, Reenat S Hasan, BS, Karen E Danis, MA, Irene Y Cheung, ScD, Bo Dupont, MD, DSc, Nai Kong Cheung, MD, PhD, Katharine C Hsu, MD, PhD

Blood (2008) 112 (11): 3322.

https://doi.org/10.1182/blood.V112.11.3322.3322

Published: 2008

Journal Articles

IL-15 Augments in-Vitro Expansion and Functional Activity of Antigen-Specific Effector Memory T-Cells (T EM ) While Co-Expression of IL-15 and IL-15 Rα on Antigen Presenting Cells Also Promotes Expansion of Central Memory T-Cells (T CM )

Aisha Hasan, MD, Annamalai Selvakumar, PhD, Bo Dupont, MD, DSc, Michel Sadelain, MD, Isabelle Riviere, PhD, Richard J O’Reilly, MD

Blood (2008) 112 (11): 3541.

https://doi.org/10.1182/blood.V112.11.3541.3541

Published: 2008

Journal Articles

The Activating KIR2DS2 Gene Influences NK Alloreactivity and NK Repertoire.

Joseph H. Chewning, MD, Charlotte N. Gudme, PhD, Glenn Heller, PhD, Bo Dupont, MD, DSc

Blood (2007) 110 (11): 313.

https://doi.org/10.1182/blood.V110.11.313.313

Published: 2007

Journal Articles

The Activating KIR Genes 2DS1 and 2DS2 Regulate NK Alloreactivity In Vitro.

Joseph H. Chewning, MD, Charlotte N. Gudme, PhD, Bo Dupont, MD, DSc

Blood (2006) 108 (11): 927.

https://doi.org/10.1182/blood.V108.11.927.927

Published: 2006

Journal Articles

Lack of Predictive Value of KIR-HLA Genotypes for Autologous Transplant Outcome for Multiple Myeloma.

Katharine C. Hsu, MD, PhD, Guido Tricot, MD PhD, Jeff Haessler, PhD, Clara Pinto-Agnello, MS, Frits van Rhee, MD PhD, Michelle Fox, MD, Bo Dupont, MD DSc

Blood (2006) 108 (11): 3078.

https://doi.org/10.1182/blood.V108.11.3078.3078

Published: 2006

Journal Articles

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes

Katharine C. Hsu, Carolyn A. Keever-Taylor, Andrew Wilton, Clara Pinto, Glenn Heller, Knarik Arkun, Richard J. O'Reilly, Mary M. Horowitz, Bo Dupont

Blood (2005) 105 (12): 4878–4884.

https://doi.org/10.1182/blood-2004-12-4825

Published: 2005

Includes: Supplemental data

Journal Articles

The Effect of Killer Immunoglobulin-Like Receptor (KIR) Ligand Incompatibility on Outcome of Unrelated Donor Bone Marrow Transplantation (UDT).

Sherif Farag, Andrea Bacigalupo, Bo Dupont, Michael Caligiuri, Gene Nelson, Jeffrey Miller, Stella Davies

Blood (2004) 104 (11): 434.

https://doi.org/10.1182/blood.V104.11.434.434

Published: 2004

Journal Articles

The yin-yang in immunity

Bo Dupont

Blood (2004) 104 (10): 3002–3003.

https://doi.org/10.1182/blood-2004-08-3321

Published: 2004

Journal Articles

Quantitation, selection, and functional characterization of Epstein-Barr virus–specific and alloreactive T cells detected by intracellular interferon-γ production and growth of cytotoxic precursors

Guenther Koehne, Katherine M. Smith, Teresa L. Ferguson, Roxanne Y. Williams, Glenn Heller, Eric G. Pamer, Bo Dupont, Richard J. O'Reilly

Blood (2002) 99 (5): 1730–1740.

https://doi.org/10.1182/blood.V99.5.1730

Published: 2002

Journal Articles

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

Effie W. Petersdorf, Craig Kollman, Carolyn Katovich Hurley, Bo Dupont, Auayporn Nademanee, Ann B. Begovich, Daniel Weisdorf, Philip McGlave

Blood (2001) 98 (10): 2922–2929.

https://doi.org/10.1182/blood.V98.10.2922

Published: 2001

NARROW

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

Genetic Allelic Variation in the p53 DNA Repair Pathway Constitute a Risk Factor for Long-Term Survival in Hematopoietic Stem Cell Transplantation

Lack of HLA Class I Ligands for Autologous Inhibitory KIR Is Associated with Improved Survival Following Autologous Stem Cell Transplant for Children with Neuroblastoma.

IL-15 Augments in-Vitro Expansion and Functional Activity of Antigen-Specific Effector Memory T-Cells (T EM ) While Co-Expression of IL-15 and IL-15 Rα on Antigen Presenting Cells Also Promotes Expansion of Central Memory T-Cells (T CM )

The Activating KIR2DS2 Gene Influences NK Alloreactivity and NK Repertoire.

The Activating KIR Genes 2DS1 and 2DS2 Regulate NK Alloreactivity In Vitro.

Lack of Predictive Value of KIR-HLA Genotypes for Autologous Transplant Outcome for Multiple Myeloma.

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes

The Effect of Killer Immunoglobulin-Like Receptor (KIR) Ligand Incompatibility on Outcome of Unrelated Donor Bone Marrow Transplantation (UDT).

The yin-yang in immunity

Quantitation, selection, and functional characterization of Epstein-Barr virus–specific and alloreactive T cells detected by intracellular interferon-γ production and growth of cytotoxic precursors

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only